CATAPULT THERAPEUTICS
Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody. The chemokine receptor CCR7 is over-expressed in many cancers, and high CCR7 expression is associated with poor prognosis and short survival in hematological and solid malignancies. Preclinical studies have shown that the anti-CCR7 antibody can prolong survival and inhibit cancer cell migration in multiple animal models of B-cell and T-cell lymphomas.
CATAPULT THERAPEUTICS
Industry:
Biotechnology
Address:
Lelystad, Flevoland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.catapult-therapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Gubra
Gubra is a privately-held biotech company
Current Employees Featured
Official Site Inspections
http://www.catapult-therapeutics.com
- Host name: web0120.zxcs.nl
- IP address: 185.104.29.84
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam